MURRAY WITTNER, M.D., Ph.D.; KENNETH S. ROWIN, M.D.; HERBERT B. TANOWITZ, M.D.; JEAN F. HOBBS, M.D.; SIMONE SALTZMAN, M.D.; BARRY WENZ, M.D.; ROBERT HIRSCH, M.D.; EMILY CHISHOLM; GEORGE R. HEALY, Ph.D.
We describe babesiosis transmitted by transfusion. The infected blood donor was identified and a minimum period of infectivity of the donor's blood was established. We report a new modality for chemotherapy consisting of quinine plus clindamycin, and a new endemic focus for this zoonosis on Fire Island, New York. There are insufficient data to establish a reasonably safe period after which visitors and residents of Babesia-endemic foci can become blood donors. Screening of such persons by a rapid serologic test, such as the ELISA or immunofluorescent antibody tests, is suggested.
Learn more about subscription options.
Register Now for a free account.
WITTNER M, ROWIN KS, TANOWITZ HB, HOBBS JF, SALTZMAN S, WENZ B, et al. Successful Chemotherapy of Transfusion Babesiosis. Ann Intern Med. 1982;96:601–604. doi: 10.7326/0003-4819-96-5-601
Download citation file:
Published: Ann Intern Med. 1982;96(5):601-604.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only